Literature DB >> 21177896

Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.

Clotilde Rousseau1, Florence Levenez, Charlène Fouqueray, Joël Doré, Anne Collignon, Patricia Lepage.   

Abstract

Clostridium difficile is a major enteric pathogen responsible for antibiotic-associated diarrhea. Host susceptibility to C. difficile infections results partly from inability of the intestinal microbiota to resist C. difficile colonization. During early infancy, asymptomatic colonization by C. difficile is common and the intestinal microbiota shows low complexity. Thus, we investigated the potential relationship between the microbiota composition and the implantation of C. difficile in infant gut. Fecal samples from 53 infants, ages 0 to 13 months, 27 negative and 26 positive for C. difficile, were studied. Dominant microbiota profiles were assessed by PCR-temporal temperature gradient gel electrophoresis (TTGE). Bacterial signatures of the intestinal microbiota associated with colonization by C. difficile were deciphered using principal component analysis (PCA). Resulting bands of interest in TTGE profiles were excised, sequenced, and analyzed by nucleotide BLAST (NCBI). While global biodiversity was not affected, interclass PCA on instrumental variables highlighted significant differences in dominant bacterial species between C. difficile-colonized and noncolonized infants (P = 0.017). Four bands were specifically associated with the presence or absence of C. difficile: 16S rRNA gene sequences related to Ruminococcus gnavus and Klebsiella pneumoniae for colonized infants and to Bifidobacterium longum for noncolonized infants. We demonstrated that the presence of C. difficile in the intestinal microbiota of infants was associated with changes in this ecosystem's composition. These results suggest that the composition of the gut microbiota might be crucial in the colonization process, although the chronology of events remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177896      PMCID: PMC3067754          DOI: 10.1128/JCM.01507-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Authors:  Vincent B Young; Thomas M Schmidt
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge.

Authors:  M F De La Cochetière; T Durand; P Lepage; A Bourreille; J P Galmiche; J Doré
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Authors:  Ju Young Chang; Dionysios A Antonopoulos; Apoorv Kalra; Adriano Tonelli; Walid T Khalife; Thomas M Schmidt; Vincent B Young
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

Review 4.  Generalized linear mixed models: a review and some extensions.

Authors:  C B Dean; Jason D Nielsen
Journal:  Lifetime Data Anal       Date:  2007-11-14       Impact factor: 1.588

5.  Clostridium difficile and Clostridium perfringens species detected in infant faecal microbiota using 16S rRNA targeted probes.

Authors:  Matteo Fallani; Lionel Rigottier-Gois; Marga Aguilera; Chantal Bridonneau; Anne Collignon; Christine A Edwards; Gérard Corthier; Joël Doré
Journal:  J Microbiol Methods       Date:  2006-05-02       Impact factor: 2.363

6.  Factors influencing the composition of the intestinal microbiota in early infancy.

Authors:  John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

7.  Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection.

Authors:  M J Hopkins; G T Macfarlane
Journal:  J Med Microbiol       Date:  2002-05       Impact factor: 2.472

8.  Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile.

Authors:  Séverine Péchiné; Claire Janoir; Hélène Boureau; Aude Gleizes; Nicolas Tsapis; Sandra Hoys; Elias Fattal; Anne Collignon
Journal:  Vaccine       Date:  2007-03-07       Impact factor: 3.641

9.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

Review 10.  The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease.

Authors:  R C Spencer
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

View more
  57 in total

Review 1.  Sex differences in the gut microbiome-brain axis across the lifespan.

Authors:  Eldin Jašarević; Kathleen E Morrison; Tracy L Bale
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-02-01       Impact factor: 6.237

2.  Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.

Authors:  Mathilde Payen; Ioannis Nicolis; Marie Robin; David Michonneau; Johanne Delannoye; Camille Mayeur; Nathalie Kapel; Béatrice Berçot; Marie-José Butel; Jérôme Le Goff; Gérard Socié; Clotilde Rousseau
Journal:  Blood Adv       Date:  2020-05-12

3.  Effect of Metronidazole in Infants with Bowel Habit Change: Irrelative to the Clostridium difficile Colonization.

Authors:  Eun Jin Kim; Sung Hyun Lee; Hann Tchah; Eell Ryoo
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-03-27

Review 4.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

5.  Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae.

Authors:  Angela E Reeves; Mark J Koenigsknecht; Ingrid L Bergin; Vincent B Young
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

6.  Carriage of Clostridium difficile by wild urban Norway rats (Rattus norvegicus) and black rats (Rattus rattus).

Authors:  Chelsea G Himsworth; David M Patrick; Sunny Mak; Claire M Jardine; Patrick Tang; J Scott Weese
Journal:  Appl Environ Microbiol       Date:  2013-12-06       Impact factor: 4.792

7.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

8.  The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species.

Authors:  E Goldberg; I Amir; M Zafran; U Gophna; Z Samra; S Pitlik; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-19       Impact factor: 3.267

Review 9.  Beyond phylotyping: understanding the impact of gut microbiota on host biology.

Authors:  Christopher S Reigstad; Purna C Kashyap
Journal:  Neurogastroenterol Motil       Date:  2013-05       Impact factor: 3.598

Review 10.  Clostridium difficile and the microbiota.

Authors:  Anna M Seekatz; Vincent B Young
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.